Around 80% of GLP-1 users anticipated needing new clothing in a January survey by research firm Circana, and 55% had already bought new items, according to a July survey by the firm
Second, the doses are small because the target is a high-affinity intracellular enzyme, not a receptor that needs saturating with milligrams of drug
Dietary habits, prevalence of obesity and overweight in developed and developing countries
As GLP-1s grow more accessiblethanks to microdosing, efforts to make the drugs more affordable, and the pending release of a weight-loss pilltheir impact will be more deeply felt beyond food to sectors including apparel, wellness, beauty, and restaurants
Forest plot of GLP-1 receptor agonists versus comparators on the risk of pneumonia
Weight Management: While not a weight-loss drug, the modest weight loss or weight-neutral effect associated with metformin can be beneficial for overweight or obese patients with diabetes